PATENT CLAIM ANALYSIS

Application Number: 15869162
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["424", "059000"]

Abstract:
Addition of magnesium stearate to a powder formulation for inhalation comprising carrier particles and an active ingredient bearing a group susceptible to hydrolysis is useful for inhibiting or reducing the chemical degradation of the active ingredient.

Claim (Index 1):
A method of inhibiting or reducing chemical degradation of a phosphodiesterase-4 inhibitor bearing a group susceptible to hydrolysis selected from the group consisting of a carbonate group and an ester group, in a powder formulation for inhalation comprising carrier particles and the phosphodiesterase-4 inhibitor, said method comprising: coating a surface of said carrier particles with magnesium stearate in preparation of the powder formulation.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 86.0
- Lexical Diversity: 1.23333
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14607289', '10592701', '14820939', '13078057', '13195885']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7233885272625451
- 35 USC 102 Novelty (BERT): 0.5063904129971368
- Combined Prediction Score: 0.7016887158360042
- Mean Citation Score: 232.15262
- Max Citation Score: 247.23987
- Similarity Product: 157.7510207815164

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test